Which closed-end funds own Krystal Biotech Inc?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $9.3M. Security type: common equity. Country: United States. CUSIP 501147102 · ISIN US5011471027 · ticker KRYS.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 0.54% | $3.7M | 10,037 sh | $690M | 3.4% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.41% | $5.6M | 15,104 sh | $1.4B | 7.1% discount | Jun 30, 2026 |
| BRW Saba Capital Income & Opportunities Fund | U.S. Equity | -0.01% | $-48.1K | -141 sh | $351M | 17.0% discount | Jul 31, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “KRYS” → · Compare two funds’ portfolios →